EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

A systematic review of the barriers and facilitators impacting patient enrolment in clinical trials for lung cancer

Benjamin Lond, Christopher Dodd, Zoe Davey, Liz Darlison, John McPhelim, Janette Rawlinson, Iain Williamson, Clair Merriman, Francesca Waddington, Dominic Bagnallainslie, Balaji Rajendran, Jesse Usman und 1 weitere

European Journal of Oncology Nursing · 2024

DOI: 10.1016/j.ejon.2024.102564 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Oncology Nursing, 2024. Verfasst von Benjamin Lond und 12 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Institute of Applied Health Research, Oxford Brookes University, Oxford, United Kingdom. Electronic address: blond@brookes.ac.uk. Hauptthemen laut MEDLINE: Lung Neoplasms, Patient Selection, Clinical Trials as Topic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roy Castle Lung Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Clinical research trials are needed to enhance the medical care and treatment for lung cancer, which remains the leading cause of cancer-related deaths worldwide. While clinical trials allow for the development of novel therapies to treat cancer, the recruitment of lung cancer patients to trials is low. This review aimed to identify and synthesise the available literature concerning barriers and facilitators affecting lung cancer patients' decisions to enrol in clinical trials to guide future cancer research efforts. METHODS: Four databases were systematically searched: Academic Search Complete, CINHAL, PubMed, and PsycINFO in August 2023. A supplemental grey literature search was also conducted alongside this. Articles were quality appraised using CASP and JMI checklists, and results were narratively synthesised. RESULTS: Eighteen articles of varied design met the inclusion criteria, and results were mapped onto the Capability, Opportunity, and Motivation Behaviour (COM-B) Model to help structure and conceptualise review findings. Evidence suggests that the decision to enrol in a trial is multifaceted and informed by: when and how study information is presented, travel and trial eligibility, and altruistic hopes and fears. CONCLUSIONS: There is need to address the many different concerns that lung cancer patients have about participating in a clinical trial through the supply of accessible and timely trial information, and via the reduction of travel, expansion of study eligibility criteria, and recognition of a person's altruistic wishes, hopes, fears, and family-oriented concerns. Future research should aim to work alongside lung cancer patients, clinicians, and other stakeholders to increase research accessibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsPatient SelectionClinical Trials as TopicHumansDecision MakingPatient ParticipationMotivation

Stichwörter der Autor:innen

Clinical trialsLung cancerRecruitmentSystematic review

Autor:innen und Institutionen

  • Oxford Institute of Applied Health Research, Oxford Brookes University, Oxford, United Kingdom. Electronic address: blond@brookes.ac.uk.
  • Oxford Institute of Applied Health Research, Oxford Brookes University, Oxford, United Kingdom.
  • University Hospitals of Leicester, The Glenfield Hospital, Leicester, United Kingdom.
  • University Hospital Hairmyres, NHS Lanarkshire, East Kilbride, United Kingdom.
  • Lung Cancer Patient Advisory Group, European Lung Foundation, Sheffield, United Kingdom; British Thoracic Oncology Group Steering Committee, Leicester, United Kingdom.
  • Division of Psychology, De Montfort University, Leicester, United Kingdom.

Förderung

  • Roy Castle Lung Cancer Foundation

Zitieren

APA

Lond, B., Dodd, C., Davey, Z., Darlison, L., McPhelim, J., Rawlinson, J., Williamson, I., Merriman, C., Waddington, F., Bagnallainslie, D., Rajendran, B., Usman, J., & Henshall, C. (2024). A systematic review of the barriers and facilitators impacting patient enrolment in clinical trials for lung cancer. European Journal of Oncology Nursing. https://doi.org/10.1016/j.ejon.2024.102564

Vancouver

Lond B, Dodd C, Davey Z, Darlison L, McPhelim J, Rawlinson J, et al. A systematic review of the barriers and facilitators impacting patient enrolment in clinical trials for lung cancer. European Journal of Oncology Nursing. 2024. doi:10.1016/j.ejon.2024.102564

BibTeX
@article{Lond2024,
  author = {Lond, Benjamin and Dodd, Christopher and Davey, Zoe and Darlison, Liz and McPhelim, John and Rawlinson, Janette and Williamson, Iain and Merriman, Clair and Waddington, Francesca and Bagnallainslie, Dominic and Rajendran, Balaji and Usman, Jesse and Henshall, Catherine},
  title = {A systematic review of the barriers and facilitators impacting patient enrolment in clinical trials for lung cancer},
  journal = {European Journal of Oncology Nursing},
  year = {2024},
  doi = {10.1016/j.ejon.2024.102564}
}
Kostenlos starten →